Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Methylbenactyzium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 8/20 | 0.94 |
| ▸ | CHRM2 known ✓ | P08172 | 7/20 | 0.94 |
| ▸ | CHRM3 known ✓ | P20309 | 6/20 | 0.94 |
| ▸ | SLC6A3 known ✓ | Q01959 | 1/20 | 0.62 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.94 |
| ▸ | SCN1A | P35498 | 2/20 | 0.67 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.67 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.67 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.50 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.49 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylbenactyzium SCHEMBL669744 | 0.99 | CHRM1 (0.97) | CHRM1CHRM2CHRM3CHRM4SCN1A | |
| Methylbenactyzium SCHEMBL60901 | 0.97 | CHRM1 (1.00) | CHRM1CHRM2CHRM3CHRM4SCN1A | |
| Methylbenactyzium SCHEMBL8446490 | 0.94 | CHRM1 (0.95) | CHRM1CHRM2CHRM3CHRM4SCN1A | |
| Lachesine SCHEMBL1946024 | 0.89 | CHRM1 (0.75) | CHRM1CHRM2CHRM3CHRM4SCN1A | |
| Lachesine SCHEMBL3638169 | 0.87 | CHRM1 (0.73) | CHRM1CHRM2CHRM3CHRM4SCN1A | |
| Oxitefonium SCHEMBL29388802 | 0.85 | CHRM1 (0.73) | CHRM1CHRM2CHRM3CHRM4SCN1A | |
| Metocinium SCHEMBL2108327 | 0.85 | CHRM2 (0.74) | CHRM1CHRM2CHRM3CHRM4SCN1A | |
| Oxitefonium SCHEMBL2733669 | 0.84 | CHRM1 (0.76) | CHRM1CHRM2CHRM3CHRM4SCN1A | |
| Metocinium SCHEMBL2732726 | 0.84 | CHRM2 (0.72) | CHRM1CHRM2CHRM3CHRM4SCN1A | |
| SCHEMBL5158545 | 0.80 | MEN1 (0.68) | CHRM1CHRM2CHRM3CHRM4SCN1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-9278657-A | — | — | None | — | — | JP | disclosed |
| JP-H09278657-A | USE OF ANTACID AND ANTACID-FORMULATED PREPARATION | CHUGAI PHARMACEUT CO LTD | 1997-10-28 | — | — | JP | disclosed |